These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6575917)

  • 1. Pharmacokinetics of isotretinoin during repetitive dosing to patients.
    Brazzell RK; Vane FM; Ehmann CW; Colburn WA
    Eur J Clin Pharmacol; 1983; 24(5):695-702. PubMed ID: 6575917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of isotretinoin and its major blood metabolite following a single oral dose to man.
    Colburn WA; Vane FM; Shorter HJ
    Eur J Clin Pharmacol; 1983; 24(5):689-94. PubMed ID: 6575916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of the retinoids isotretinoin and etretinate. A comparative review.
    Brazzell RK; Colburn WA
    J Am Acad Dermatol; 1982 Apr; 6(4 Pt 2 Suppl):643-51. PubMed ID: 6461675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of isotretinoin following a single oral dose.
    Khoo KC; Reik D; Colburn WA
    J Clin Pharmacol; 1982; 22(8-9):395-402. PubMed ID: 6957421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isotretinoin kinetics after 80 to 320 mg oral doses.
    Colburn WA; Gibson DM
    Clin Pharmacol Ther; 1985 Apr; 37(4):411-4. PubMed ID: 3856501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacokinetics of the retinoids.
    Lucek RW; Colburn WA
    Clin Pharmacokinet; 1985; 10(1):38-62. PubMed ID: 3882304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steady-state pharmacokinetics of isotretinoin and its 4-oxo metabolite: implications for fetal safety.
    Nulman I; Berkovitch M; Klein J; Pastuszak A; Lester RS; Shear N; Koren G
    J Clin Pharmacol; 1998 Oct; 38(10):926-30. PubMed ID: 9807973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The metabolism and pharmacokinetics of isotretinoin in patients with acne and rosacea are not influenced by ethanol.
    Grønhøj Larsen F; Jakobsen P; Grønhøj Larsen C; Heidenheim M; Held E; Nielsen-Kudsk F
    Br J Dermatol; 2009 Sep; 161(3):664-70. PubMed ID: 19563582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of route of administration and biliary excretion on the pharmacokinetics of isotretinoin in the dog.
    Cotler S; Chen S; Macasieb T; Colburn WA
    Drug Metab Dispos; 1984; 12(2):143-7. PubMed ID: 6144477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of 14C-isotretinoin in healthy volunteers and volunteers with biliary T-tube drainage.
    Colburn WA; Vane FM; Bugge CJ; Carter DE; Bressler R; Ehmann CW
    Drug Metab Dispos; 1985; 13(3):327-32. PubMed ID: 2861992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring of isotretinoin therapy by measuring the plasma levels of isotretinoin and 4-oxo-isotretinoin. A useful tool for management of severe acne.
    Almond-Roesler B; Blume-Peytavi U; Bisson S; Krahn M; Rohloff E; Orfanos CE
    Dermatology; 1998; 196(1):176-81. PubMed ID: 9557257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isotretinoin: new therapy for severe acne.
    Perry MD; McEvoy GK
    Clin Pharm; 1983; 2(1):12-9. PubMed ID: 6192964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of gut contents, intestinal wall, and liver on the first pass metabolism and absolute bioavailability of isotretinoin in the dog.
    Cotler S; Buggé CJ; Colburn WA
    Drug Metab Dispos; 1983; 11(5):458-62. PubMed ID: 6138231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developmental effects of isotretinoin and 4-oxo-isotretinoin: the role of metabolism in teratogenicity.
    Kochhar DM; Penner JD
    Teratology; 1987 Aug; 36(1):67-75. PubMed ID: 3478842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The negligible systemic availability of retinoids with multiple and excessive topical application of isotretinoin 0.05% gel (Isotrex) in patients with acne vulgaris.
    Jensen BK; McGann LA; Kachevsky V; Franz TJ
    J Am Acad Dermatol; 1991 Mar; 24(3):425-8. PubMed ID: 1829464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral retinoids in the treatment of seborrhoea and acne.
    Orfanos CE; Zouboulis CC
    Dermatology; 1998; 196(1):140-7. PubMed ID: 9557249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic study of all-trans-retinoyl-beta-D-glucuronide in Sprague-Dawley rats after single and multiple intravenous administration(s).
    Lin HS; Barua AB; Olson JA; Low KS; Chan SY; Shoon ML; Ho PC
    J Pharm Sci; 2001 Dec; 90(12):2023-31. PubMed ID: 11745761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-dose pharmacokinetic study of 13-cis-retinoic acid in man.
    Besner JG; Leclaire R; Band P; Meloche S; Deschamps M; Mailhot S; Moisan R; Diorio G
    Cancer Treat Rep; 1985 Mar; 69(3):275-7. PubMed ID: 3856478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isotretinoin. A review of its pharmacological properties and therapeutic efficacy in acne and other skin disorders.
    Ward A; Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1984 Jul; 28(1):6-37. PubMed ID: 6235105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of isotretinoin. Biliary excretion of isotretinoin glucuronide in the rat.
    Meloche S; Besner JG
    Drug Metab Dispos; 1986; 14(2):246-9. PubMed ID: 2870901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.